1. Salpietro, Vincenzo, Galassi Deforie, Valentina, Efthymiou, Stephanie, Houlden, Henry, Männikkö, Roope. 2022. De novo KCNA6 variants with attenuated KV 1.6 channel deactivation in patients with epilepsy. In Epilepsia, 64, 443-455. doi:10.1111/epi.17455. https://pubmed.ncbi.nlm.nih.gov/36318112/
2. Peck, Liam J, Patel, Ryan, Diaz, Paula, Calvo, Margarita, Bennett, David L H. 2021. Studying Independent Kcna6 Knock-out Mice Reveals Toxicity of Exogenous LacZ to Central Nociceptor Terminals and Differential Effects of Kv1.6 on Acute and Neuropathic Pain Sensation. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 41, 9141-9162. doi:10.1523/JNEUROSCI.0187-21.2021. https://pubmed.ncbi.nlm.nih.gov/34544832/
3. Van Poucke, Mario, Vanhaesebrouck, An E, Peelman, Luc J, Van Ham, Luc. 2012. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers. In Neuromuscular disorders : NMD, 22, 558-65. doi:10.1016/j.nmd.2012.01.008. https://pubmed.ncbi.nlm.nih.gov/22342001/
4. Fang, Fang, Hazegh, Kelsey, Mast, Alan E, Kanias, Tamir, Page, Grier P. 2022. Sex-specific genetic modifiers identified susceptibility of cold stored red blood cells to osmotic hemolysis. In BMC genomics, 23, 227. doi:10.1186/s12864-022-08461-4. https://pubmed.ncbi.nlm.nih.gov/35321643/
5. Lin, Wuqiang, Chen, Xiuli, Zheng, Heyong, Zhang, Beibei, Zheng, Rongrong. 2024. LncRNA CBR3-AS1 is associated with the BCR::ABL1 kinase independent mechanism of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia patients. In Translational cancer research, 13, 3262-3272. doi:10.21037/tcr-24-281. https://pubmed.ncbi.nlm.nih.gov/39145066/
智鼠故事 
